$BRVE
Braveheart Bio, Inc. Common Stock
XNAS
Why is BRVE down today? It is at $27.50 (-0.29%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BRVE spikes, and full due diligence on BRVE — key stats, earnings, dilution and insider activity. Free.
Get free $BRVE alerts the moment volume spikes
Our scanner flagged $BRVE 16 times in the last 30 days. Create a free account to track $BRVE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $27.50
- Change today
- -0.29%
- Previous close
- $27.58
- 52-week range
- $24.61 – $32.00
- Avg daily volume
- 418K
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.0x
- 1hthin
- 0.1x
- 1D
- 0.1x
Get free BRVE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $BRVE moving today?
Here is the latest on BRVE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BRVE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCharter / Bylaw Change, from an SEC filing. Read it →Latest filingSC 13DActivist 5%+ stake disclosedAug 18, 2026 · 6 days agoInsiders
Insiders buying8 open-market buys17 buys, 0 sells last 3 months (17/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lubner David Charles Director | Bought (open market) | +56K | n/a | 56K | $1000K at $18.00 | Aug 7, 26 |
Murdoch Travis Officer | Bought (open market) | +83K | added 2.9% | 2.94M | $1.5M at $18.00 | Aug 7, 26 |
Anderson Michele A. Officer | Bought (open market) | +1K | added 0.3% | 332K | $20K at $18.00 | Aug 7, 26 |
Viehbacher Christopher Director | Bought (open market) | +83K | added 16% | 610K | $1.5M at $18.00 | Aug 7, 26 |
Malek David I Director | Bought (open market) | +4K | added 0.8% | 534K | $75K at $18.00 | Aug 7, 26 |
Rickey James Paul Officer | Bought (open market) | +28K | added 5.6% | 521K | $500K at $18.00 | Aug 7, 26 |
Forbion Growth Opportunities Fund Iii Cooperatief U.A. Beneficial Owner (10%) | Acquired (grant/award) | +9.13M | added 100% | 9.72M | n/a | Aug 7, 26 |
Forbion Growth Opportunities Fund Iii Cooperatief U.A. Beneficial Owner (10%) | Acquired (grant/award) | +7.99M | added 100% | 8.51M | n/a | Aug 7, 26 |
Forbion Growth Opportunities Fund Iii Cooperatief U.A. Beneficial Owner (10%) | Bought (open market) | +1.92M | added 20% | 11.64M | $34.6M at $18.00 | Aug 7, 26 |
Forbion Growth Opportunities Fund Iii Cooperatief U.A. Beneficial Owner (10%) | Bought (open market) | +1.68M | added 20% | 10.19M | $30.2M at $18.00 | Aug 7, 26 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Beneficial Owner (10%) | Acquired (grant/award) | +7.42M | n/a | 7.42M | n/a | Aug 7, 26 |
Orbimed Advisors Llc Director | Acquired (grant/award) | +9.13M | added 100% | 10.24M | n/a | Aug 7, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $BRVE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 3,187,500 new shares · About $75.0M in size
- About $75.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$BRVE Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$BRVE Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
BRVE stock FAQ
Why is $BRVE moving today?
Here is the latest on BRVE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BRVE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the BRVE stock price today?
BRVE last traded at $27.50, down 0.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live BRVE alerts?
The BRVE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BRVE 16 times in the last 30 days.
What exchange is BRVE on?
BRVE (Braveheart Bio, Inc. Common Stock) trades on XNAS.
Is BRVE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BRVE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.